Effects of a Orally Inhaled Fluticasone Furoate on Growth Velocity in Prepubertal, Paediatric Subjects With Asthma Over a Year

Condition:   Asthma
Interventions:   Drug: Fluticasone furoate;   Drug: Placebo;   Drug: Montelukast;   Drug: Short Acting Beta 2 Agonist
Sponsor:   GlaxoSmithKline
Not yet recruiting – verified August 2016

View full post on ClinicalTrials.gov: asthma | Studies received in the last 14 days

Leave a Reply

Your email address will not be published. Required fields are marked *